LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies, Volume Eight, summarizes the molecular mechanisms of drug resistance in colorectal cancer, a… Read more
LIMITED OFFER
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies, Volume Eight, summarizes the molecular mechanisms of drug resistance in colorectal cancer, along with the most up-to-date therapeutic strategies available. The book discusses reasons why colorectal tumors become refractory during the progression of the disease, but also explains how drug resistance occurs during chemotherapy. In addition, users will find the current therapeutic strategies used by clinicians in their practice in treating colorectal cancer. The combination of conventional anticancer drugs with chemotherapy-sensitizing agents plays a pivotal role in improving the outcome of colorectal cancer patients, in particular those with drug-resistant cancer cells.
From a clinical point-of-view, the content of this book provides clinicians with updated therapeutic strategies for a better choice of drugs for drug-resistant colorectal cancer patients. It will be a valuable source for cancer researchers, oncologists and several members of biomedical field who are dedicated to better treat patients with colorectal cancer.
1. Drug resistence in colorectal cancer: General aspects
2. Drug transporters in the development of multidrug resistance in colorectal cancer
3. Role pf colorectal cancer stem cells in resistance to apoptosis and treatment in colorectal cancer
4. Serrated lesions and stem cells on drug resistance and colon cancer
5. Development of novel microRNA-based therapeutics platform for colorectal cancer
6. Chemo-sensitizing agents for naturalorigin for colorectal cancer: Pharmacokinetics approaches
7. Induction of programmed necrosis by phytochemicals in colorectal cancer
8. Predictive biomarkers of drug resistance in colorectal cancer - Recent updates
9. Raclb: An emerging therapeutic target for chemoresistance in colorectal cancer
10. Nanotechnology-based targeted drug delivery systems and drug resistance in colorectal cancer
11. Targeting colorectal cancer via nanodrug delivery systems
CC
TH